Knowledge Center

Poster / Nov 12, 2017

Optimizing Disintegration in Tablets of Amorphous Solid Dispersions

Authors:
  • Nuno Neves
  • João Henriques
  • Marcio Temtem
Source:
AAPS 2017

Good bioavailability of amorphous solid dispersions (ASDs) not only depends on dissolution rate/extent but also on the capability to inhibit/avoid crystallization, ensuring that supersaturated state is retained to promote absorption. Here, the type and amount of carrier polymer used in ADSs preparation have a strong impact on the rate and extent of precipitation.

Related links

Also in the Knowledge Center

Related Content

History of ËÄÉ«AV

ËÄÉ«AV was established in Portugal in 1959 by Ivan Villax with his wife, Diane Villax, and two other Hungarian refugees: Nicholas de Horthy and Andrew Onody, thus forming the name HOVIONE.

Page
Read more

ËÄÉ«AV partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes

Press Release / Mar 07, 2024
Article
View

API

ËÄÉ«AV inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more